BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2161770)

  • 1. In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.
    Ecclestone M; Proulx A; Ballinger JR; Gerson B; Reid RH; Gulenchyn KY
    Eur J Nucl Med; 1990; 16(4-6):299-302. PubMed ID: 2161770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.
    Tsai CS; Kao CH; Yeh SJ; Wang SJ
    Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO.
    Welling M; Feitsma HI; Blok D; Calame W; Ensing GJ; Goedemans W; Pauwels EK
    Q J Nucl Med; 1995 Jun; 39(2):89-98. PubMed ID: 8574810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of 99Tcm-HMPAO and 99Tcm-ECD as a leukocyte labelling agent.
    Kao CH; Huang WT; Wang YL; Lin KS; Lo JM; Wang SJ
    Nucl Med Commun; 1994 Apr; 15(4):294-7. PubMed ID: 8072744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
    Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new leukocyte labeling procedure with 99mTc-HMPAO.
    Kelbaek H; Linde J; Nielsen SL
    Eur J Nucl Med; 1988; 14(12):621-3. PubMed ID: 3243309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of granulocyte concentration on leukocyte labelling efficiency with 99mTc-HMPAO.
    Ballinger JR; Proulx A; Gerson B; Gulenchyn KY
    Int J Rad Appl Instrum B; 1990; 17(4):443. PubMed ID: 2387752
    [No Abstract]   [Full Text] [Related]  

  • 8. Procedure for red blood cell labelling with 99mTc-HMPAO. Methodology and quality control.
    Bassa P; García Garzón JR; Piera C; Pavía A; Minoves M; Moragas M; Pavía J; Lomeña F; Setoain J
    Nucl Med Biol; 1994 Oct; 21(7):963-7. PubMed ID: 9234351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m exametazime (99mTc-HMPAO)-labeled white blood cells: a high efficiency multidose procedure.
    Ozker K; Collier BD; Hellman RS; Isitman AT; Uzum F; Steffel FG
    Eur J Nucl Med; 1995 Feb; 22(2):182-3. PubMed ID: 7758507
    [No Abstract]   [Full Text] [Related]  

  • 10. Labelling of leukocytes with 99mTc-HMPAO for scintigraphy of inflammatory lesions and abscesses.
    Vanlić-Razumenić N; Pujić N; Dedović N; Kostić K; Nastić-Mirić D
    Int J Rad Appl Instrum B; 1992 Apr; 19(3):251-6. PubMed ID: 1629013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kit for labelling erythrocytes or leukocytes with technetium-99m.
    Proulx A; Gerson B; Ballinger JR; Gulenchyn KY
    Int J Rad Appl Instrum B; 1990; 17(5):515-7. PubMed ID: 2391248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoradiography and density gradient separation of technetium-99m-exametazime (HMPAO) labelled leucocytes reveals selectivity for eosinophils.
    Puncher MR; Blower PJ
    Eur J Nucl Med; 1994 Nov; 21(11):1175-82. PubMed ID: 7859768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and functional status of leukocytes labelled with 99m technetium HMPAO.
    De Labriolle-Vaylet C; Linhart NC; Petiet A; Bok B
    Prog Clin Biol Res; 1990; 355():119-29. PubMed ID: 2177895
    [No Abstract]   [Full Text] [Related]  

  • 14. [99mTc-HMPAO labeling of leukocytes and thrombocytes. Characteristics and diagnostic consequences].
    Becker W; Börner W
    Rofo; 1988 Jan; 148(1):69-74. PubMed ID: 2829311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stabilization of 99m Tc-HMPAO with methylene blue: its use in leukocyte labelling)].
    García Seguí V; Roca Engroñat M; Armero Muñoz F; Iglesias Allende F; Gomes Barreto de Mélo V; Martin-Comín J
    Rev Esp Med Nucl; 1998; 17(4):261-4. PubMed ID: 9721341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
    Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte labeling with 99mTc-HMPAO. The role of the in vitro stability of HMPAO on the labeling efficacy and image quality.
    Papós M; Láng J; Rajtár M; Csernay L
    Nucl Med Biol; 1994 Aug; 21(6):893-5. PubMed ID: 9234340
    [No Abstract]   [Full Text] [Related]  

  • 18. Tc-99m-HMPAO labelled human platelets: in vitro and in vivo results.
    Becker W; Borst U; Krahe T; Börner W
    Eur J Nucl Med; 1989; 15(6):296-301. PubMed ID: 2767079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of Tc-99m D,L-HMPAO preparations as a leucocyte labelling agent.
    Kao CH; Huang WT; Tsai CS
    Appl Radiat Isot; 1998 Dec; 49(12):1595-8. PubMed ID: 9745694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oxime.
    Danpure HJ; Osman S; Carroll MJ
    Nucl Med Commun; 1988 Jun; 9(6):465-75. PubMed ID: 3412734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.